Ser1834
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser1834  -  p300 (human)

Site Information
MLRRRMAsMQRTGVV   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 447591

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mutation of modification site ( 1 , 2 , 4 ) , phospho-antibody ( 1 , 4 ) , western blotting ( 1 )
Disease tissue studied:
lung cancer ( 4 )
Relevant cell line - cell type - tissue:
A431 (epithelial) ( 2 ) , A549 (pulmonary) ( 4 ) , NHF (fibroblast) ( 1 )

Upstream Regulation
Putative in vivo kinases:
Akt1 (human) ( 1 , 3 , 4 )
Kinases, in vitro:
Akt1 (human) ( 4 , 5 )
Treatments:
LY294002 ( 1 , 4 ) , SB203580 ( 1 ) , SH-5 ( 4 ) , TNF ( 4 ) , UV ( 1 )

Downstream Regulation
Effects of modification on p300:
molecular association, regulation ( 4 )
Effects of modification on biological processes:
transcription, induced ( 4 )
Induce interaction with:
CAF-1A (human) ( 4 )

References 

1

Wang QE, et al. (2013) p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair. Nucleic Acids Res 41, 1722-33
23275565   Curated Info

2

Chen YJ, Wang YN, Chang WC (2007) ERK2-mediated C-terminal serine phosphorylation of p300 is vital to the regulation of epidermal growth factor-induced keratin 16 gene expression. J Biol Chem 282, 27215-28
17623675   Curated Info

3

Liu Y, et al. (2006) Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J Biol Chem 281, 31359-68
16926151   Curated Info

4

Huang WC, Chen CC (2005) Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25, 6592-602
16024795   Curated Info

5

Guo S, et al. (2001) Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta. J Biol Chem 276, 8516-23
11116148   Curated Info